A Pragmatic Randomized Feasibility Trial of Influenza VaccinesNiklas Dyrby Johansen, Tor Biering‐Sørensen, Camille Salamand et al.|NEJM Evidence|2023Cited by 68
Feasibility of randomizing Danish citizens aged 65–79 years to high-dose quadrivalent influenza vaccine vs. standard-dose quadrivalent influenza vaccine in a pragmatic registry-based setting: rationale and design of the DANFLU-1 TrialNiklas Dyrby Johansen, Tor Biering‐Sørensen, Daniel Modin et al.|Pilot and Feasibility Studies|2022Cited by 24